Bria L Macklin, S. Gerecht
Feb 1, 2017
Current opinion in chemical engineering
As cardiovascular disease continues to take the lives of so many patients, it is paramount that scientists and engineers construct reliable, lasting vascular therapies. Stem cell therapies for cardiovascular disease have the potential to provide patient-specific treatments in order to heal or replace the diseased vasculature. This review highlights recent advances in endothelial cell (EC) differentiation from human pluripotent stem cells (hPSCs). We then describe in vitro studies focusing on understanding three-dimensional vascular assembly using human primary ECs and biomaterials developed for these systems. Finally, we highlight the unprecedented opportunity that hPSC- derived ECs provide to study human vascular development for fundamental understanding and toward the development of therapeutics.